THOMAS ELLIOTT JACKS

No ORCID on file · 59 papers in corpus
2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…

2005

Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula (1) are disclosed. Such inhibitors, which include N-[4-) 3-chloro -4- floro- phenylamino) -7-(3- morpholin-4 -yl- propoxy) -quinazolin -6-yl]…